Session 4 of 8
Evolving Concepts in Dermatology Part I

About
Faculty
Learning Objectives
Intended Audience
Accreditation Statement
Credit Designation Statement
Disclosure
Disclaimer

The need for continued education is critical in these uncertain times. Therefore, the co-directors of the Fall Clinical Dermatology Conference are excited to announce our new program: the Fall Clinical Virtual Grand Rounds (FCVGR). This new online series is designed to help maintain the educational opportunities one would have if they were able to attend grand rounds in person.

FCVGR will consist of eight weekly CME sessions on a variety of dermatological diseases and tools.

The Wednesday May 6, 2020 session is now available on-demand.

EVOLVING CONCEPTS IN DERMATOLOGY PART I
Amy McMichael, MD: Managing Challenging Hair Issues
Laura Ferris, MD, PhD: Update on Genomics in Skin Cancer Diagnosis and Prognosis

Laura Ferris, MD, PhD

Faculty

Associate Professor of Dermatology
University of Pittsburgh
Pittsburgh, PA

Amy McMichael, MD

Faculty

Professor and Chair, Dermatology
Wake Forest School of Medicine
Winston Salem, NC

Upon completion of this activity, the participant should be better able to:

Discuss the challenges in hair disorders evaluation and treatment with topics including frontal fibrosing alopecia, central centrifugal cicatricial alopecia, alopecia areata, and pseudofolliculitis barbae
Review new data on diagnostic and prognostic gene expression profiling tests

This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and the Foundation for Research and Education in Dermatology. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

The Institute designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by educational grants from Almirall, Bristol-Myers Squibb, and Mayne Pharma.

CONFLICTS OF INTEREST/DISCLOSURES

Laura Ferris, MD

Consultant: DermTech, Scibase

Grant/Research Support: Castle Biosciences

Amy McMichael, MD

Consultant: Johnson & Johnson, Procter & Gamble, Allergan, Bayer, Galderma, Incyte, Samumed, Aclaris, Anacor, Pfizer, Nutrafol, Bioniz, Allmirall, Revian

Investigator: Allergan, Intendis, Procter & Gamble, Samumed, Casseopia, Concert, Alcaris, Incyte

Cathy Pagano (Institute for Continuing Healthcare Education) has disclosed that she has no relevant financial relationships specific to the subject matter within the past 12 months.

[fc+258]

Session 4 of 8 Evolving Concepts in Dermatology Part I

Laura Ferris, MD, PhD

Amy McMichael, MD

CONFLICTS OF INTEREST/DISCLOSURES

Session 4 of 8
Evolving Concepts in Dermatology Part I